Following the signing of a Memorandum of Understanding/Cooperation Agreement (MOU) between the MIT startup Sunflower and Bioinnovo, Kerry Love, PhD and Laura Crowell, PhD visited Vetanco at its corporate headquarters. The purpose of the meeting was to ratify the MOU, which detailed the scope of work optimizing several innovative platforms using…
Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a molecule developed by the latter The renewed partnership provides Bioinnovo with the international rights to use Algenex’s APCH (antigen presenting cells homing) molecule in the _eld of animal health. Bioinnovo…
Bioinnovo, the technology-based public-private company formed by the National Institute of Agricultural Technology (INTA) and Vetanco SA, agree to renew their contract with Algenex for the use of the APCH molecule, the targeting protein of the innovative vaccine Vedevax BLOCK. After many years of successful…
Representatives of Vetanco met with university authorities to discuss a license contract for a recombinant vaccine, with the aim of marketing it in all American countries. Four professionals from Vetanco Argentina, headed by its president Jorge Winokur, visited the University of Concepción, Chile, to discuss the details…
The project, chosen as “The Best Patent in Latin America”, is registered in the National Institute of Industrial Property (INPI in Spanish) by the discovery of nano antibodies of Llama (Lama glama) capable of neutralizing rotavirus variants origin of viral diarrhea in children and animals….
Bioinnovo, a company formed by INTA and Vetanco, introduced vedevax BLOCK to the market. It is the first recombinant vaccine against a virus present in 90% of establishments, which causes more than 42,000 abortions every year. Bovine Viral Diarrhea virus (BVDV) has a great impact on local livestock production and…
On December 7, at the Cultural Center of Sciences, Buenos Aires, Argentina, more than 400 people participated in the meeting “Agro 2030: Innovation for development,” organized by the program “Argentina 2030” of the Presidency of the Cabinet of Ministers, together with INTA and the Argentinian…
Dr Andrés Wigdorovitz, Head of INCUINTA, CICVyA, INTA, CONICET’s Head Researcher, Bioinnovo’ Scientific Director, gave an exclusive interview to Canal Rural. Click here to watch the interview
Bioinnovo, the public-private company established by a partnership between Vetanco and INTA laboratories, was granted the InnovarAward by the Argentinian Ministry of Science and Technology for Bioinnovo IgY DNT, the first biological product based on IgY technology, and licensed for the prevention of Neonatal Calf Diarrhea….
We share with you the interview with Dr Andrés Wigdorovitz, Head of INCUINTA, CICVyA and INTA, Head Researcher of CONICET, and Scientific Director of Bioinnovo, on La Nación+ TV channel. FIRST PART SECOND PART